Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma

Journal of Clinical Oncology

Volumn 19, Issue 17, 2001, Pages 3740-3744

  De Santis, M ^a   Bokemeyer, C ^a   Becherer, A ^a   Stoiber, F ^a   Oechsle, K ^a   Kletter, K ^a   Dohmen, B M ^a   Dittrich, C ^a   Pont, J ^a  

^a KAISER FRANZ JOSEF HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; PLATINUM;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MALE; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEMINOMA; TREATMENT OUTCOME;

EID: 0035449028     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.17.3740     Document Type: Article

References (23)

1. Advanced seminoma: Treatment with cisplatinum-based combination chemotherapy or carboplatinum (JM 8)
2. Residual mass: An indication for further therapy in patients with advanced seminoma following systemic chemotherapy
3. Management of residual mass in advanced seminoma: Results and recommendations from the Memorial Sloan-Kettering Cancer Center
4. Residual mass following chemotherapy of seminoma
5. Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
6. Radiotherapy after chemotherapy for metastatic seminoma: A diminishing role
7. VAB-6 as initial treatment of patients with advanced seminomas
8. Therapeutic guidelines and results in advanced seminoma
9. Surgery for a postchemotherapy residual mass in seminoma
10. Response evaluation in seminoma
11. Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience
12. Nuclear medicine in cancer diagnosis
13. Performance characteristics of a whole-body PET scanner
14. ECAT ART: A continuously rotating PET camera - Performance characteristics initial clinical studies, and installation considerations in a nuclear medicine department
15. FDG PET imaging of paragangliomas of the neck: Comparison with MIBG SPET
16. Salvage chemotherapy with vinblastine, ifosfamide and cisplatin in recurrent seminoma
17. Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients
18. Management of the postchemotherapy residual mass
19. Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma
20. SUV: Standard uptake or silly useless value?
21. Quantifications of serial tumor glucose metabolism
22. Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET
23. FDG PET for detection and therapy control of metastatic germ cell tumor